Some of the communities most at risk for Alzheimer's disease continue to be underrepresented in clinical trials-and new research from the Keck...
Vous n'êtes pas connecté
Blood-based biomarkers show why diverse groups are underrepresented in Alzheimer's trials, raising questions about risk factors beyond amyloid.
Some of the communities most at risk for Alzheimer's disease continue to be underrepresented in clinical trials-and new research from the Keck...
BAVINA SOOKDEO SEPTEMBER is Alzheimer’s Awareness Month and neurologist Dr Nicholas Maraj is urging the nation to face the growing challenge of...
Alzheimer's disease, a significant concern for older adults, lacks a cure, prompting research into lifestyle factors like omega-3 fatty acids. Found...
Alzheimer's disease, a significant concern for older adults, lacks a cure, prompting research into lifestyle factors like omega-3 fatty acids. Found...
Scientists at Emory University’s Goizueta Brain Health Institute and partner institutions have identified proteins in the blood that may shed new...
Paris: After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting...
Blood cell. Credits: Andrew Mason, CC BY-NC 2.0, via Flickr Scientists at Emory University’s Goizueta Brain Health Institute and partner...
Blood cell. Credits: Andrew Mason, CC BY-NC 2.0, via Flickr Scientists at Emory University’s Goizueta Brain Health Institute and partner...
A new study is shedding light on why some of the people most at risk for Alzheimer’s disease are missing from clinical trials. Researchers from the...
A new study is shedding light on why some of the people most at risk for Alzheimer’s disease are missing from clinical trials. Researchers from the...